MRC Clinical Trials Unit at UCL
2nd Floor
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.stampede@ucl.ac.uk
Since we opened back in 2005, up until the last comparisons finally closed to recruitment in 2023, almost 12,000 men have participated in the life-changing research of the STAMPEDE trial. Thank you to all the sites who have contributed to the success of the trial and who are still following up participants from the final comparisons.
You can see the final recruitment figures sorted by trial arm in the table below.
Trial Arm | Date Recruitment Ended | Total |
A: SOC | Closed to recruitment 31-Mar-2023 | 4,754 |
B: SOC + ZA | Closed to recruitment 31-Mar-2013 | 593 |
C: SOC + Doc | Closed to recruitment 31-Mar-2013 | 592 |
D: SOC + Cel | Closed to recruitment 06-Apr-2011 | 312 |
E: SOC + ZA + Doc | Closed to recruitment 31-Mar-2013 | 593 |
F: SOC + ZA + Cel | Closed to recruitment 06-Apr-2011 | 311 |
G: SOC + Abi | Closed to recruitment 17-Feb-2014 | 960 |
H: SOC + RT | Closed to recruitment 02-Sep-2016 | 1,032 |
J: SOC + Abi + Enza | Closed to recruitment 31-Mar-2016 | 989 |
K: SOC + Metformin | Closed to recruitment 31-Mar-2023 | 1,509 |
L: tE2 +/- RT +/- Doc | Closed to recruitment 31-Mar-2023 | 347 |
All Arms | 11,992 |
STAMPEDE
MRC Clinical Trials Unit at UCL
2nd Floor
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.stampede@ucl.ac.uk
STAMPEDE
Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy
See the latest News in STAMPEDE through the link to the right.